# Poland drug safety bans and recalls

> Live situation record from CLSTR: https://clstr.news/situations/poland-drug-recall-actions
> Updated: 2026-07-31T14:18:16.000Z. Sources: 10. Developments: 2.

In late July 2026 Poland’s chief drug regulator, the Główny Inspektorat Farmaceutyczny (GIF), ordered a nationwide withdrawal of Concor 5 mg and Concor Cor 5 mg hypertension tablets after testing identified nitrosamine N‑Nitroso‑Bisoprolol (NBP) above the permissible limit. The contamination was traced to specific batches produced between November 2022 and September 2023 by Merck and to parallel‑imported batches from Bulgaria and Spain, with the auxiliary substance supplier excluded from production. Patients were instructed to stop using the tablets and return them for replacement.

A week later GIF issued a second urgent recall, this time of Adnamil 300 mg allopurinol tablets used for gout and kidney stones. The recall targeted a single batch from Polfarmex S.A. after inspection revealed a white powdery coating, tablet damage, and excessive resistance to crushing, raising concerns about the drug’s release and safety. Distribution of the batch was banned across Poland.

On 31 July 2026 the regulator expanded its actions, prohibiting the introduction of Atorvastatin Medical Valley tablets across all series because coating defects could compromise stability and efficacy, and reaffirming the withdrawal of the contaminated Concor batches. In the same announcement the national sanitary inspection warned of Listeria monocytogenes in a batch of raw sausage, and the Ministry of Health reported that the anti‑export list now covers 288 medicines, about 1.6 % of authorized products.

## Timeline

### 2026-07-31: Polish health regulator bans multiple medicines and issues safety alerts

Poland bans Atorvastatin Medical Valley and Concor batches over quality issues, warns of Listeria in raw sausage, and maintains a 288‑drug anti‑export list.

6 sources. https://clstr.news/cluster/polish-health-regulator-withdraws-adnamil-allopurinol-tablets-from-pharmacies

### 2026-07-23: Poland recalls Concor 5 mg hypertension tablets over nitrosamine contamination

Poland's drug regulator ordered the recall of Concor 5 mg hypertension tablets after nitrosamine N‑Nitroso‑Bisoprolol contamination was found in specific batches from Merck, Bulgarian and Spanish imports; users

5 sources. https://clstr.news/cluster/poland-recalls-concor-5-mg-hypertension-tablets-over-nitrosamine-contamination

---
Cite as: Poland drug safety bans and recalls. CLSTR, https://clstr.news/situations/poland-drug-recall-actions